| scholarly article | Q13442814 |
| P50 | author | Kiyoshi Kubota | Q88993654 |
| P2093 | author name string | Hajime Iizuka | |
| Hidemi Nakagawa | |||
| Daisuke Koide | |||
| Nobuhiro Ooba | |||
| Tsugumichi Sato | |||
| Yukari Kamijima | |||
| P2860 | cites work | Risk of Myocardial Infarction in Patients With Psoriasis | Q60711909 |
| Psoriasis and hypertension: a case-control study | Q82672156 | ||
| Epidemiological study of psoriasis in the national health insurance database in Taiwan | Q83943423 | ||
| Global epidemiology of psoriasis: a systematic review of incidence and prevalence | Q26991871 | ||
| Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis | Q27007133 | ||
| Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. | Q34478064 | ||
| Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008. | Q34632618 | ||
| The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. | Q36602668 | ||
| Heart disease in psoriasis | Q36791247 | ||
| Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis | Q36914874 | ||
| Pustulosis palmoplantaris is a disease distinct from psoriasis | Q37778079 | ||
| The association between psoriasis and dyslipidaemia: a systematic review | Q38056160 | ||
| Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study. | Q44664672 | ||
| Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. | Q46272550 | ||
| Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. | Q47300306 | ||
| Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan | Q48304403 | ||
| Prevalence of psoriasis in China: a population-based study in six cities | Q48398399 | ||
| Genetic Analysis of PSORS1 Distinguishes Guttate Psoriasis and Palmoplantar Pustulosis | Q57149334 | ||
| P433 | issue | 1 | |
| P921 | main subject | database | Q8513 |
| epidemiology | Q133805 | ||
| generalized pustular psoriasis | Q5532501 | ||
| pustulosis | Q7262033 | ||
| P304 | page(s) | e006450 | |
| P577 | publication date | 2015-01-14 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database | |
| P478 | volume | 5 |
| Q30248242 | A systematic review of worldwide epidemiology of psoriasis |
| Q47242645 | Analysis of treatment goal alignment between Japanese psoriasis patients and their paired treating physicians |
| Q41540546 | Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial |
| Q64883748 | Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy. |
| Q35934076 | Association between Psoriasis Vulgaris and Coronary Heart Disease in a Hospital-Based Population in Japan |
| Q54981634 | Association of high psychiatrist staffing with prolonged hospitalization, follow-up visits, and readmission in acute psychiatric units: a retrospective cohort study using a nationwide claims database. |
| Q48236525 | Biologic treatments for elderly patients with psoriasis. |
| Q89017592 | Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts |
| Q48144520 | Clinical characteristics of Japanese patients with psoriatic arthritis: Comparison with East Asian countries. |
| Q35815759 | Cutting Edge: PD-1 Regulates Imiquimod-Induced Psoriasiform Dermatitis through Inhibition of IL-17A Expression by Innate γδ-Low T Cells |
| Q59806666 | Delayed Diagnosis of Psoriatic Arthritis Mutilans due to Arthritis Prior to Skin Lesion |
| Q98945468 | Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations |
| Q93149160 | Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter study |
| Q38838614 | Economic burden of psoriatic patients in Japan: Analysis from a single outpatient clinic |
| Q91577568 | Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial |
| Q50126864 | Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical Trial. |
| Q33626095 | Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J) |
| Q40164166 | Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1). |
| Q47586451 | Epidemiological survey from 2009 to 2012 of psoriatic patients in Japanese Society for Psoriasis Research. |
| Q48163947 | Epidemiological survey of patients with psoriasis in Matsumoto city, Nagano Prefecture, Japan. |
| Q40338652 | Epidemiology and cardiovascular comorbidities in patients with psoriasis: A Korean nationwide population-based cohort study |
| Q61813523 | Familial Aggregation of Psoriasis and Co-Aggregation of Autoimmune Diseases in Affected Families |
| Q53835593 | Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study. |
| Q57705930 | Guselkumab, an anti-interleukin-23 monoclonal antibody, for the treatment of moderate to severe plaque-type psoriasis in Japanese patients: Efficacy and safety results from a phase 3, randomized, double-blind, placebo-controlled study |
| Q54917709 | Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis. |
| Q58708700 | Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study |
| Q40129865 | Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients |
| Q89087181 | Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study |
| Q64110151 | Increased risk of migraine in patients with psoriasis: A longitudinal follow up study using a national sample cohort |
| Q50058093 | Initially undetected de novo psoriasis triggered by nivolumab for metastatic base of the tongue carcinoma |
| Q30251957 | Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review. |
| Q90600981 | Interstitial Pneumonia in Psoriasis |
| Q51435941 | Long-term clinical safety and efficacy of brodalumab in the treatment of Japanese patients with moderate-to-severe plaque psoriasis. |
| Q57467413 | Long-term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: Subgroup analyses of an open-label, phase 3 study (UNCOVER-J) |
| Q39472493 | Mutation analysis of IL36RN gene in Japanese patients with palmoplantar pustulosis |
| Q90179749 | Nonclinical safety of tildrakizumab, a humanized anti-IL-23p19 monoclonal antibody, in nonhuman primates |
| Q48023865 | Number needed to treat and costs per responder among biologic treatments for moderate-to-severe plaque psoriasis in Japan |
| Q37345488 | Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study |
| Q48162560 | PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin. |
| Q64078295 | Palmoplantar Pustulosis and Allergies: A Systematic Review |
| Q89486229 | Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments |
| Q58098228 | Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan |
| Q93092083 | Patient preference for biologic treatments of psoriasis in Japan |
| Q55652012 | Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database. |
| Q64882724 | Position Statement on Secukinumab in the Management of Plaque Psoriasis: The Malaysian Perspective. |
| Q59808441 | Positive predictive value of ICD-10 codes for acute myocardial infarction in Japan: a validation study at a single center |
| Q47100186 | Prevalence of Psoriasis in Korea: A Population-Based Epidemiological Study Using the Korean National Health Insurance Database |
| Q48170767 | Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups. |
| Q91260267 | Risk of End-Stage Renal Disease in Psoriatic Patients: Real-World Data from a Nationwide Population-Based Cohort Study |
| Q37412858 | Safety and efficacy of adalimumab treatment in Japanese patients with psoriasis: Results of SALSA study |
| Q48148751 | Safety and efficacy of guselkumab in Japanese patients with moderate-to-severe plaque psoriasis: a randomized, placebo-controlled, ascending-dose study |
| Q47930789 | Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long-term differential effects of biologics |
| Q53089186 | Serum interleukin-6 levels in response to biologic treatment in patients with psoriasis. |
| Q40132474 | Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial. |
| Q50247726 | UVA1 vs. narrowband UVB phototherapy in the treatment of palmoplantar pustulosis: a pilot randomized controlled study |
| Q38926801 | What do we know about palmoplantar pustulosis? |
Search more.